vs

Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and COMMUNITY FINANCIAL SYSTEM, INC. (CBU). Click either name above to swap in a different company.

Astera Labs, Inc. is the larger business by last-quarter revenue ($270.6M vs $214.5M, roughly 1.3× COMMUNITY FINANCIAL SYSTEM, INC.). COMMUNITY FINANCIAL SYSTEM, INC. runs the higher net margin — 26.7% vs 16.6%, a 10.0% gap on every dollar of revenue. On growth, Astera Labs, Inc. posted the faster year-over-year revenue change (91.8% vs 8.7%). Over the past eight quarters, Astera Labs, Inc.'s revenue compounded faster (103.6% CAGR vs 7.9%).

Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.

Community Health Systems (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

ALAB vs CBU — Head-to-Head

Bigger by revenue
ALAB
ALAB
1.3× larger
ALAB
$270.6M
$214.5M
CBU
Growing faster (revenue YoY)
ALAB
ALAB
+83.1% gap
ALAB
91.8%
8.7%
CBU
Higher net margin
CBU
CBU
10.0% more per $
CBU
26.7%
16.6%
ALAB
Faster 2-yr revenue CAGR
ALAB
ALAB
Annualised
ALAB
103.6%
7.9%
CBU

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ALAB
ALAB
CBU
CBU
Revenue
$270.6M
$214.5M
Net Profit
$45.0M
$57.2M
Gross Margin
75.6%
Operating Margin
24.7%
Net Margin
16.6%
26.7%
Revenue YoY
91.8%
8.7%
Net Profit YoY
82.0%
15.3%
EPS (diluted)
$0.25
$1.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALAB
ALAB
CBU
CBU
Q1 26
$214.5M
Q4 25
$270.6M
$217.0M
Q3 25
$230.6M
$208.1M
Q2 25
$191.9M
$200.5M
Q1 25
$159.4M
$197.3M
Q4 24
$141.1M
$197.4M
Q3 24
$113.1M
$190.3M
Q2 24
$76.8M
$184.3M
Net Profit
ALAB
ALAB
CBU
CBU
Q1 26
$57.2M
Q4 25
$45.0M
$54.4M
Q3 25
$91.1M
$55.1M
Q2 25
$51.2M
$51.3M
Q1 25
$31.8M
$49.6M
Q4 24
$24.7M
$49.8M
Q3 24
$-7.6M
$43.9M
Q2 24
$-7.5M
$47.9M
Gross Margin
ALAB
ALAB
CBU
CBU
Q1 26
Q4 25
75.6%
Q3 25
76.2%
Q2 25
75.8%
Q1 25
74.9%
Q4 24
74.0%
Q3 24
77.7%
Q2 24
77.9%
Operating Margin
ALAB
ALAB
CBU
CBU
Q1 26
Q4 25
24.7%
33.1%
Q3 25
24.0%
35.2%
Q2 25
20.7%
32.9%
Q1 25
7.1%
32.6%
Q4 24
0.1%
32.7%
Q3 24
-7.9%
30.0%
Q2 24
-31.7%
33.7%
Net Margin
ALAB
ALAB
CBU
CBU
Q1 26
26.7%
Q4 25
16.6%
25.1%
Q3 25
39.5%
26.5%
Q2 25
26.7%
25.6%
Q1 25
20.0%
25.1%
Q4 24
17.5%
25.2%
Q3 24
-6.7%
23.1%
Q2 24
-9.8%
26.0%
EPS (diluted)
ALAB
ALAB
CBU
CBU
Q1 26
$1.15
Q4 25
$0.25
$1.03
Q3 25
$0.50
$1.04
Q2 25
$0.29
$0.97
Q1 25
$0.18
$0.93
Q4 24
$1.23
$0.94
Q3 24
$-0.05
$0.83
Q2 24
$-0.05
$0.91

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALAB
ALAB
CBU
CBU
Cash + ST InvestmentsLiquidity on hand
$167.6M
$572.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.4B
$2.0B
Total Assets
$1.5B
$17.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALAB
ALAB
CBU
CBU
Q1 26
$572.2M
Q4 25
$167.6M
$301.8M
Q3 25
$140.4M
$245.2M
Q2 25
$162.3M
$237.2M
Q1 25
$86.4M
$518.0M
Q4 24
$79.6M
$197.0M
Q3 24
$126.1M
$346.1M
Q2 24
$421.1M
$201.5M
Total Debt
ALAB
ALAB
CBU
CBU
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$990.2M
Q3 24
Q2 24
Stockholders' Equity
ALAB
ALAB
CBU
CBU
Q1 26
$2.0B
Q4 25
$1.4B
$2.0B
Q3 25
$1.3B
$1.9B
Q2 25
$1.1B
$1.9B
Q1 25
$1.0B
$1.8B
Q4 24
$964.8M
$1.8B
Q3 24
$889.6M
$1.8B
Q2 24
$845.3M
$1.7B
Total Assets
ALAB
ALAB
CBU
CBU
Q1 26
$17.5B
Q4 25
$1.5B
$17.3B
Q3 25
$1.4B
$17.0B
Q2 25
$1.3B
$16.7B
Q1 25
$1.1B
$16.8B
Q4 24
$1.1B
$16.4B
Q3 24
$983.1M
$16.4B
Q2 24
$915.5M
$15.9B
Debt / Equity
ALAB
ALAB
CBU
CBU
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.56×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALAB
ALAB
CBU
CBU
Operating Cash FlowLast quarter
$95.3M
Free Cash FlowOCF − Capex
$76.6M
FCF MarginFCF / Revenue
28.3%
Capex IntensityCapex / Revenue
6.9%
Cash ConversionOCF / Net Profit
2.12×
TTM Free Cash FlowTrailing 4 quarters
$281.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALAB
ALAB
CBU
CBU
Q1 26
Q4 25
$95.3M
$301.9M
Q3 25
$78.2M
$101.1M
Q2 25
$135.4M
$53.7M
Q1 25
$10.5M
$62.5M
Q4 24
$39.7M
$242.3M
Q3 24
$63.5M
$56.9M
Q2 24
$29.8M
$39.8M
Free Cash Flow
ALAB
ALAB
CBU
CBU
Q1 26
Q4 25
$76.6M
$233.3M
Q3 25
$65.9M
$83.4M
Q2 25
$133.3M
$36.4M
Q1 25
$6.0M
$52.0M
Q4 24
$24.3M
$221.6M
Q3 24
$46.8M
$51.9M
Q2 24
$28.5M
$33.8M
FCF Margin
ALAB
ALAB
CBU
CBU
Q1 26
Q4 25
28.3%
107.5%
Q3 25
28.6%
40.1%
Q2 25
69.5%
18.1%
Q1 25
3.7%
26.3%
Q4 24
17.2%
112.2%
Q3 24
41.4%
27.3%
Q2 24
37.1%
18.3%
Capex Intensity
ALAB
ALAB
CBU
CBU
Q1 26
Q4 25
6.9%
31.6%
Q3 25
5.3%
8.5%
Q2 25
1.1%
8.6%
Q1 25
2.8%
5.3%
Q4 24
10.9%
10.5%
Q3 24
14.8%
2.6%
Q2 24
1.7%
3.3%
Cash Conversion
ALAB
ALAB
CBU
CBU
Q1 26
Q4 25
2.12×
5.55×
Q3 25
0.86×
1.84×
Q2 25
2.64×
1.05×
Q1 25
0.33×
1.26×
Q4 24
1.61×
4.87×
Q3 24
1.30×
Q2 24
0.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons